BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32444437)

  • 1. Spirometry performed as part of the Manchester community-based lung cancer screening programme detects a high prevalence of airflow obstruction in individuals without a prior diagnosis of COPD.
    Balata H; Harvey J; Barber PV; Colligan D; Duerden R; Elton P; Evison M; Greaves M; Howells J; Irion K; Karunaratne D; Mellor S; Newton T; Sawyer R; Sharman A; Smith E; Taylor B; Taylor S; Tonge J; Walsham A; Whittaker J; Vestbo J; Booton R; Crosbie PA
    Thorax; 2020 Aug; 75(8):655-660. PubMed ID: 32444437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of lung cancer risk model (PLCO
    Lebrett MB; Balata H; Evison M; Colligan D; Duerden R; Elton P; Greaves M; Howells J; Irion K; Karunaratne D; Lyons J; Mellor S; Myerscough A; Newton T; Sharman A; Smith E; Taylor B; Taylor S; Walsham A; Whittaker J; Barber PV; Tonge J; Robbins HA; Booton R; Crosbie PAJ
    Thorax; 2020 Aug; 75(8):661-668. PubMed ID: 32631933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of COPD in the SUMMIT Study lung cancer screening cohort using symptoms and spirometry.
    Tisi S; Dickson JL; Horst C; Quaife SL; Hall H; Verghese P; Gyertson K; Bowyer V; Levermore C; Mullin AM; Teague J; Farrelly L; Nair A; Devaraj A; Hackshaw A; ; Hurst JR; Janes SM
    Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35896207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, Symptom Burden, and Underdiagnosis of Chronic Obstructive Pulmonary Disease in a Lung Cancer Screening Cohort.
    Ruparel M; Quaife SL; Dickson JL; Horst C; Tisi S; Hall H; Taylor MN; Ahmed A; Shaw PJ; Burke S; Soo MJ; Nair A; Devaraj A; Sennett K; Hurst JR; Duffy SW; Navani N; Bhowmik A; Baldwin DR; Janes SM
    Ann Am Thorac Soc; 2020 Jul; 17(7):869-878. PubMed ID: 32164439
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis and treatment outcomes from prebronchodilator spirometry performed alongside lung cancer screening in a Lung Health Check programme.
    Bradley C; Boland A; Clarke L; Dallinson N; Eckert C; Ellames D; Finn J; Gabe R; Hancock N; Kennedy MP; Lindop J; Mohamed A; Mullen G; Murray RL; Rogerson S; Shinkins B; Simmonds I; Upperton S; Wilkinson A; Crosbie PA; Callister ME
    Thorax; 2023 Jun; 78(6):543-550. PubMed ID: 36972979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attending community-based lung cancer screening influences smoking behaviour in deprived populations.
    Balata H; Traverse-Healy L; Blandin-Knight S; Armitage C; Barber P; Colligan D; Elton P; Kirwan M; Lyons J; McWilliams L; Novasio J; Sharman A; Slevin K; Taylor S; Tonge J; Waplington S; Yorke J; Evison M; Booton R; Crosbie PAJ
    Lung Cancer; 2020 Jan; 139():41-46. PubMed ID: 31726252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Airway tree caliber heterogeneity and airflow obstruction among older adults.
    Vameghestahbanati M; Kingdom L; Hoffman EA; Kirby M; Allen NB; Angelini E; Bertoni A; Hamid Q; Hogg JC; Jacobs DR; Laine A; Maltais F; Michos ED; Sack C; Sin D; Watson KE; Wysoczanksi A; Couper D; Cooper C; Han M; Woodruff P; Tan WC; Bourbeau J; Barr RG; Smith BM;
    J Appl Physiol (1985); 2024 May; 136(5):1144-1156. PubMed ID: 38420676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and predictors of airflow obstruction in an HIV tertiary care clinic in Montreal, Canada: a cross-sectional study.
    Costiniuk CT; Nitulescu R; Saneei Z; Wasef N; Salahuddin S; Wasef D; Young J; de Castro C; Routy JP; Lebouché B; Cox J; Smith BM; Ambroise S; Pexos C; Patel M; Szabo J; Haraoui LP; de Pokomandy A; Tsoukas C; Falutz J; LeBlanc R; Giannakis A; Frenette C; Jenabian MA; Bourbeau J; Klein MB
    HIV Med; 2019 Mar; 20(3):192-201. PubMed ID: 30620136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of undiagnosed airflow obstruction among people with a history of smoking in a primary care setting.
    Fu SN; Yu WC; Wong CK; Lam MC
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2391-2399. PubMed ID: 27729780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, symptom burden and under-diagnosis of chronic obstructive pulmonary disease in Polish lung cancer screening population: a cohort observational study.
    Undrunas A; Kasprzyk P; Rajca A; Kuziemski K; Rzyman W; Zdrojewski T
    BMJ Open; 2022 Apr; 12(4):e055007. PubMed ID: 35410926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic screening for COPD in primary care: a pooled analysis of 6,710 symptomatic smokers and ex-smokers.
    Katsimigas A; Tupper OD; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1633-1638. PubMed ID: 31413558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underdiagnosis of COPD: The Japan COPD Real-World Data Epidemiological (CORE) Study.
    Koga Y; Deguchi S; Matsuo T; Suzuki A; Terashima G; Tajima T; Shibata Y; Sagara H
    Int J Chron Obstruct Pulmon Dis; 2024; 19():1011-1019. PubMed ID: 38737192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating eligibility for lung cancer screening in an Australian cohort, including the effect of spirometry.
    Manners D; Hui J; Hunter M; James A; Knuiman MW; McWilliams A; Mulrennan S; Musk AW; Brims FJ
    Med J Aust; 2016 Jun; 204(11):406. PubMed ID: 27318396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between airflow obstruction and coronary atherosclerosis in asymptomatic individuals: evaluation by coronary CT angiography.
    Kim JJ; Kim DB; Jang SW; Cho EJ; Chang K; Baek SH; Youn HJ; Chung WS; Seung KB; Rho TH; Jung JI; Hwang BH
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):641-648. PubMed ID: 29139033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of COPD as Predictors of Lung Cancer.
    Carr LL; Jacobson S; Lynch DA; Foreman MG; Flenaugh EL; Hersh CP; Sciurba FC; Wilson DO; Sieren JC; Mulhall P; Kim V; Kinsey CM; Bowler RP
    Chest; 2018 Jun; 153(6):1326-1335. PubMed ID: 29452098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between chronic obstructive pulmonary disease and lung cancer in African American patients.
    Mina N; Soubani AO; Cote ML; Suwan T; Wenzlaff AS; Jhajhria S; Samarah H; Schwartz AG
    Clin Lung Cancer; 2012 Mar; 13(2):149-56. PubMed ID: 22129972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
    Goffin JR; Pond GR; Puksa S; Tremblay A; Johnston M; Goss G; Nicholas G; Martel S; Bhatia R; Liu G; Schmidt H; Atkar-Khattra S; McWilliams A; Tsao MS; Tammemagi MC; Lam S
    BMC Pulm Med; 2020 Nov; 20(1):300. PubMed ID: 33198781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early Detection of COPD: An Opportunistic Case Finding Study in Smokers and Ex-Smokers Visiting a Medical Centre.
    Rokach A; Bohadana A; Kotek O; Shuali CC; Azulai H; Babai P; Freier-Dror Y; Izbicki G
    Int J Chron Obstruct Pulmon Dis; 2021; 16():1519-1527. PubMed ID: 34103909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should we be screening for COPD? - looking through the lens of lung cancer screening.
    Young RP; Scott RJ
    Expert Rev Respir Med; 2023; 17(9):753-771. PubMed ID: 37728077
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.